Medacta Group SA Stock

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:31:55 2024-05-08 am EDT 5-day change 1st Jan Change
116 CHF +1.22% Intraday chart for Medacta Group SA +4.13% -7.64%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 596M 639M 581M Sales 2025 * 665M 714M 649M Capitalization 2.37B 2.54B 2.31B
Net income 2024 * 72M 77.24M 70.25M Net income 2025 * 84M 90.11M 81.96M EV / Sales 2024 * 4.23 x
Net Debt 2024 * 151M 162M 147M Net Debt 2025 * 143M 153M 139M EV / Sales 2025 * 3.77 x
P/E ratio 2024 *
32.1 x
P/E ratio 2025 *
28.1 x
Employees 1,696
Yield 2024 *
0.67%
Yield 2025 *
0.77%
Free-Float 30.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.22%
1 week+4.13%
Current month+4.13%
1 month-1.02%
3 months-11.31%
6 months+1.05%
Current year-7.64%
More quotes
1 week
112.40
Extreme 112.4
118.00
1 month
107.80
Extreme 107.8
122.40
Current year
107.80
Extreme 107.8
135.00
1 year
98.10
Extreme 98.1
135.00
3 years
76.70
Extreme 76.7
173.00
5 years
39.80
Extreme 39.8
173.00
10 years
39.80
Extreme 39.8
173.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 18-10-31
Director of Finance/CFO 56 07-12-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 20-12-17
Director/Board Member 67 18-12-31
Director/Board Member 59 18-12-31
More insiders
Date Price Change Volume
24-05-08 116 +1.22% 11,085
24-05-07 114.6 +0.70% 7,272
24-05-06 113.8 +0.53% 5,847
24-05-03 113.2 +0.18% 11,758
24-05-02 113 +1.44% 8,330

Delayed Quote Swiss Exchange, May 08, 2024 at 11:31 am EDT

More quotes
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
118.8 EUR
Average target price
147 EUR
Spread / Average Target
+23.68%
Consensus

Quarterly revenue - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW